China Traditional Chinese Medicine Holdings Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.7yrs
Gemiddelde ambtstermijn bestuur	5.8yrs

Recente managementupdates

Recent updates

CEO

China Traditional Chinese Medicine Holdings heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jun Yang	Chairman	less than a year	geen gegevens	geen gegevens
Hongjian Li	President & Executive Director	less than a year	geen gegevens	geen gegevens
Lixin Shen	VP & Financial Director	3.2yrs	geen gegevens	geen gegevens
Dongji Zhao	VP, Joint Company Secretary	7.3yrs	CN¥1.56m	geen gegevens
Sau Mei Ng	Joint Company Secretary	2.7yrs	geen gegevens	geen gegevens

2.7yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 570 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jun Yang	Chairman	less than a year	geen gegevens	geen gegevens
Hongjian Li	President & Executive Director	less than a year	geen gegevens	geen gegevens
Rong Xie	Independent Non-Executive Director	11.8yrs	CN¥279.00k	geen gegevens
Ling Qin	Independent Non-Executive Director	5.8yrs	CN¥279.00k	geen gegevens
Tze Shan Yu	Independent Non-Executive Director	11yrs	CN¥279.00k	geen gegevens
Weidong Li	Independent Non-Executive Director	5.8yrs	CN¥279.00k	geen gegevens
Wenming Yang	Non-Executive Director	5.9yrs	CN¥2.60m	geen gegevens
Binghua Yang	Non-Executive Director	5.9yrs	geen gegevens	geen gegevens
Xueren Cheng	Non-Executive Director	2.7yrs	CN¥2.49m	geen gegevens
Ru Li	Non-Executive Director	5.8yrs	geen gegevens	geen gegevens
Qingxin Meng	Non-Executive Director	2yrs	geen gegevens	geen gegevens
Kan Wang	Non-Executive Director	5.9yrs	geen gegevens	geen gegevens

5.8yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 570 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).

China Traditional Chinese Medicine Holdings Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments

China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes

China Traditional Chinese Medicine Holdings Co. Limited, Annual General Meeting, Jun 14, 2024

Less than half of directors are independent

China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023

China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes

Recent updates

Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others.

Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others.

First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023)

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments

New major risk - Revenue and earnings growth

First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023)

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2024 Results on Aug 28, 2024

Investor sentiment deteriorates as stock falls 15%

China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes

China Traditional Chinese Medicine Holdings Co. Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.15 in FY 2022)

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

Investor sentiment deteriorates as stock falls 20%

Investor sentiment improves as stock rises 17%

First half 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.082 in 1H 2022)

China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2023 Results on Aug 29, 2023

China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.052 per share at 1.3% yield

China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022

Full year 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.38 in FY 2021)

China Traditional Chinese Medicine Holdings Co. Limited Provides Earning Guidance for the Year Ended 31 December 2022

Investor sentiment improved over the past week

China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes

Less than half of directors are independent

China Traditional Chinese Medicine Holdings Co. Limited Do Not Recommend the Payment of an Interim Dividend for the Six Months Ended 30 June 2022

First half 2022 earnings released: EPS: CN¥0.082 (vs CN¥0.18 in 1H 2021)

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2022 Results on Aug 26, 2022

Investor sentiment deteriorated over the past week

China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2021, Payable on 29 July 2022

Upcoming dividend of HK$0.074 per share

China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021

China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive Changes

Full year 2021 earnings released: EPS: CN¥0.38 (vs CN¥0.33 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.38 (vs CN¥0.33 in FY 2020)

Investor sentiment improved over the past week

Now 20% undervalued

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First half 2021 earnings released: EPS CN¥0.18 (vs CN¥0.14 in 1H 2020)

Upcoming dividend of HK$0.067 per share

First half 2021 earnings released: EPS CN¥0.18 (vs CN¥0.14 in 1H 2020)

Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.32 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.32 in FY 2019)

China Traditional Chinese Medicine Holdings Co. Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: HK$4.77

New 90-day high: HK$4.05

New 90-day high: HK$3.84

New 90-day high: HK$3.65

New 90-day low: HK$3.14

New 90-day low: HK$3.15

First half earnings released

China Traditional Chinese Medicine Holdings Co. Limited Not Recommends Interim Dividend for the Six Months Ended 30 June 2020

New 90-day low - HK$3.31

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2020 Results on Aug 21, 2020

First half earnings released

China Traditional Chinese Medicine Holdings Co. Limited Recommends No Interim Dividend for the Six Months Ended 30 June 2020

CEO

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur